have characterized herein the heterogeneity of the CD90+ population at each stage of hepatocarcinogenesis using a computer-assisted immunohistochemical staining evaluation method for quantitative analysis on tissue…
Title: The therapeutic efficacy of CD90-targeted liposomes in pulmonary carcinoma. Background: In refractory lung cancer tissue, it has been reported that cell populations exist that exhibit resistance to existing…
characterized as MSC with flow-cytometry after reaching 80-90% confluency as they were CD90+, CD73+, CD105+, CD34-, CD45, HLA-DR-/Low and vimentin+ (Immunohistochemistry). These were differentiated
positive. However when cultured, between 15-90% of the c-Kit negative cells expressed CD90, SSEA4 or TRA-1-60, in varying amounts . There was persistence of stem cell markers ... including expression of SSEA4, TRA-1-60…
prognosis. Patients and methods: Using Muli-color flowcytometry, we analyzed the expression of CD90, 96, 117 and 123 among [CD34+/CD38-] cell population in AML patients at initial diagnosis. Results ... found that…
tumor metastasis, chemoresistance and post-treatment recurrence. Different markers, including CD13, CD24, CD44, CD90, CD133 and EpCAM, have been reported as specific surface markers to enrich CSCs in HCC. Many ... with…
Adherent cells, isolated from all examined tissues, express phenotype characteristic for naïve MSC: CD73, CD90, CD105, however their expression down-regulated during follow-up period (after P7). A fraction…
flow cytometry and molecular methods based on expression of mesenchymal and endothelial specific markers (CD90, CD73, CD105, vWF, CD31, VEGF, VEGFR2). Potential angiogenic activity of WJ-EPC was evaluated ... Both cell…
MSCs is their trans-differentiation property. Identification of MSCs is accepted by their CD105, CD90 and CD73 markers expression. In lipo aspirate from buttocks and abdominal adipose tissue, these markers…
cells per se) from patients' tumors and adjacent non tumorous mucosa were prepared. CD44+/-/CD90+/- subcultures were characterized in terms of tumorogenicity. The mixed CD90− + CD90+ cultures showed lower formation
mesenchymal stem cells (MSCs) with or without monoclonal antibodies conjugated nanoparticles against VEGF and CD90 in an experimental hepatocellular carcinoma (HCC) model. . Serum samples were collected and analyzed…
hypoxic conditions with 5 % of oxygen in atmosphere. The cells demonstrated CD105+, CD73+, CD90+, CD44+, CD45-, CD34- phenotype, ability to differntiation in adipogenic, chondrogenic and osteogenic directions and higher…
GmbH, Bergisch Gladbach, Germany) was utilized which contained antibodies against MSC-related markers CD73, CD90, and CD105 independently and antibodies against haematopoietic markers CD14, CD20, CD34, and CD45…
surface markers, canonical 5'-nucleotidase surface markers, ecto (CD73) or NT5E, thymocyte antigen 1 (CD90) or Thy-1 and Endoglin CD105), were initially described as unique for mesenchymal stromal cells ... AlexaFluor…
count was 45.66 × 104 cells/ml on thday of culture with 99.6% viability, CD45-CD90+,8.53 × 104 cells/ ml and CD45-CD73+, 5.69 × 104 cells/ml in α-MEM versus ... cells/ml with 90.5% viability, CD45-CD90+ 1.8 × 104…
MSCs presented a high percentage of cells expressing CD29 and CD90 and a low percentage expressing CD31, CD34, CD44 and CD45. OBs displayed higher gene expression
shape was performed by light microscopy. Analysis of MSC markers expression (presence of CD73, CD90, CD105, absence of CD14, CD20, CD34, CD45) was performed by flow cytometry (Beckman Coulter, FC500 ... After culture…
compromise lineage progenitors. This work compares the expansion factor (EF) of HSC CD34+/CD90+/CD49f+ using two models of expansion (static and perfusion), the model incorporates mesenchymal cells of Wharton ... CD146+…
vitro express elevated levels of ASCs markers typical for mesenchymal stem cells (CD73, CD90, CD105, CD29). The variable level of expression was observed for CD31 and CD34, what seems
prognosis. Patients and methods: Using Muli-color flowcytometry, we analyzed the expression of CD90, 96, 117 and 123 among [CD34+/CD38-] cell population in AML patients at initial diagnosis. Results ... found that…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.